Clinical prevalence (diagnosed cases) of monoclonal gammopathy of undetermined significance in the US: estimating the burden on health care

Leukemia. 2016 Jun;30(6):1443-6. doi: 10.1038/leu.2015.336. Epub 2015 Dec 9.

Authors

R S Go^{1

2}, K M Swanson², L R Sangaralingham², E B Habermann², N D Shah^{2

3}

Affiliations

¹ Division of Hematology, Mayo Clinic, Rochester, MN, USA.
² Robert D and Patricia E Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN, USA.
³ Optum Labs, Cambridge, MA, USA.

PMID: 26648533
DOI: 10.1038/leu.2015.336

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adolescent
Aged
Aged, 80 and over
Female
Humans
Male
Middle Aged
Monoclonal Gammopathy of Undetermined Significance / epidemiology*
Prevalence
Retrospective Studies
United States / epidemiology
Young Adult